Literature DB >> 8890904

Enhancement of ELISAs for screening peptides in epitope phage display libraries.

P Valadon1, M D Scharff.   

Abstract

The complete analysis of epitope phage display libraries requires sensitive assays capable of detecting peptides expressed on phage that have a wide range of affinities for antibody. We have compared two ELISAs, a 'direct' assay where the phage is captured by an anti-phage antibody and the peptide detected by the antibody used for screening, and a 'reverse' assay where the antibody used for screening is first coated on the well and the binding of phage detected by the anti-phage antibody. We demonstrate, by comparing two fUSE5 derived phage bearing five peptides reacting with the anti-cryptococcal polysaccharide antibody 2H1, that the reverse ELISA is the more sensitive assay. Further, there is a limit in affinity, here around 1 microM, above which phage clones are negative by the direct ELISA. We describe an enhancement of the direct assay by mixing 2H1 with 3-fold excess of anti-heavy or anti-light chain antibody. The resulting polymerization of 2H1 induces an increase in antibody avidity that is responsible for the enhancement. The enhanced direct ELISA allowed rapid and sensitive detection of positive clones and is easily inhibited by free peptide, while the reverse ELISA is not. The enhanced ELISA has also been used successfully for immunological screening of intermediate libraries, allowing detection of rare positive clones that would otherwise be lost. The combination of the three ELISAs, reverse, direct, and enhanced direct, should provide a way to rank phage clones into three classes: very low, low, and high affinity, providing information previously obtained only by the synthesis and testing of many peptides.

Entities:  

Mesh:

Substances:

Year:  1996        PMID: 8890904     DOI: 10.1016/0022-1759(96)00133-0

Source DB:  PubMed          Journal:  J Immunol Methods        ISSN: 0022-1759            Impact factor:   2.303


  4 in total

1.  Use of real-time polymerase chain reaction to identify cell- and tissue-type-selective peptides by phage display.

Authors:  David L Jaye; Frederick S Nolte; Luca Mazzucchelli; Cissy Geigerman; Adil Akyildiz; Charles A Parkos
Journal:  Am J Pathol       Date:  2003-05       Impact factor: 4.307

2.  Characterization of structurally defined epitopes recognized by monoclonal antibodies produced by chronic lymphocytic leukemia B cells.

Authors:  Till Seiler; Manuela Woelfle; Sophia Yancopoulos; Rosa Catera; Wentian Li; Katerina Hatzi; Carol Moreno; Marcela Torres; Santanu Paul; Hartmut Dohner; Stephan Stilgenbauer; Matthew S Kaufman; Jonathan E Kolitz; Steven L Allen; Kanti R Rai; Charles C Chu; Nicholas Chiorazzi
Journal:  Blood       Date:  2009-08-18       Impact factor: 22.113

3.  Epitope location in the Cryptococcus neoformans capsule is a determinant of antibody efficacy.

Authors:  G Nussbaum; W Cleare; A Casadevall; M D Scharff; P Valadon
Journal:  J Exp Med       Date:  1997-02-17       Impact factor: 14.307

4.  Identification of B-Cell Epitopes with Potential to Serologicaly Discrimnate Dengue from Zika Infections.

Authors:  Alice F Versiani; Raissa Prado Rocha; Tiago A O Mendes; Glauco C Pereira; Jordana Graziella A Coelho Dos Reis; Daniella C Bartholomeu; Flávio G da Fonseca
Journal:  Viruses       Date:  2019-11-19       Impact factor: 5.048

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.